AB-434

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAB-434
Drug Alias NameVEGF-2 receptor kinase inhibitor (Ambit)AB-434
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonists
TargetsVascular endothelial growth factor receptor 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmbit Biosciences Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmbit Biosciences Co
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A